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Objectives. This study examined the temporal patterns of 
ventricular tachycardia detections by implantable cardioverter- 
defibrillators for circadian variability. 
Background. Previous studies of circadian arrhythmia patterns 
have been methodologically limited by very brief observational 
periods. Late-generation implantable cardioverter-defibrillators 
accurately record the times of arrhythmia detections during 
unlimited follow-up. 
Methods. Forty-three patients with late-generation implantable 
cardioverter-defibrillators were followed up for 226 -+ 179 days 
(mean -+ SD). The times of all recorded episodes of ventricular 
tachyarrhythmias were retrieved from the data log of each device 
during follow-up. 
Results. The weighted distribution of 830 ventricular tachyar- 
rhythmia episodes from the 43 patients fit a single harmonic sine 
curve model with a peak between 2 and 3 P.M. (95% confidence 
interval 1:13 to 4:13 P.M., R = 0.75, p < 0.05). The distributions of 
spontaneously terminating episodes, episodes receiving device 
therapy, episodes receiving shocks and episodes in the absence of 
antiarrhythmic therapy also fit the sine curve model (all R = 0.53 
and 0.73, all p < 0.05), all with peak frequencies between 2:08 and 
3:09 P.M. and 95% confidence intervals for peak frequencies 
between 11:38 A.M. and 5:07 e.M. Episodes recorded during continu- 
ous antiarrhythmic drug therapy did not fit the model (p > 0.05). 
Conclusions. The distribution of ventricular tachyarrhythmias 
detected by late-generation implantable cardioverter-defibrillators 
follows a circadian pattern, with a peak tachycardia frequency 
between oon and 5 e.~. This pattern was not observed in patients 
receiving antiarrhythmic drug therapy. Knowledge of circadian 
periodicity for these events has implications for patient manage- 
ment. 
(J Am Coil Cardiol 1995;25:901-7) 
Circadian variability has been described for the occurrences of 
many pathophysiologic cardiac events, such as sudden cardiac 
death, myocardial infarction, myocardial ischemia nd ventric- 
ular and supraventricular rhythmias (1-12). The demonstra- 
tion of circadian distributions for these events carries implica- 
tions for the further understanding and treatment of these 
disorders. Previously, the evaluation of circadian patterns of 
cardiac arrhythmias has been primarily limited to the use of 
24-h ambulatory monitor ecordings (1-3,5,13). These moni- 
tors are impractical for extended use and thus represent a
suboptimal method for the study of circadian periodicity of 
arrhythmic events. The inaccuracy inherent in inferring circa- 
dian variability to events on the basis of the observation of a 
single 24-h cycle has been likened to evaluating heart rate on 
the basis of a single cardiac cycle (14). Prolonged and contin- 
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uous observation of many 24-h cycles is necessary for the 
accurate demonstration f circadian patterns. Long-term con- 
tinuous heart rate monitoring isnow technically possible using 
implantable cardioverter-defibrillators with data storage ca- 
pacity (15). These devices can record the time, date, heart rate 
and outcome of each detected arrhythmia episode. In the 
present study data from these implanted evices were used to 
examine the hypothesis that the temporal patterns of ventric- 
ular tachyarrhythmia detections follow circadian variability. 
Methods  
Description of implantable cardioverter-defibrillators. 
The Telectronics Guardian 4210 AT[' and Cardiac Pacemaker, 
Inc. (CPI) PRx implantable cardioverter-defibrillators were 
used in this study. Both devices provide retrievable data- 
logging capabilities, including storage of the time, date, cycle 
length and device response to each tachycardia episode fulfill- 
ing detection criteria. The Guardian 4210 device has electro- 
gram storage capacity. All units utilized epicardial patch or 
transvenous endocardial leads (with or without a subcutaneous 
patch electrode) for the delivery of shock therapy. The Telec- 
tronics Guardian 4210 ATP utilizes programmable fixed-gain 
sensing amplifiers (1.0 to 5.7 mV). Tachycardia detection 
requires that the cycle lengths of the last 8 of 10, 12 of 15 or 16 
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of 20 (programmable) sensed ventricular events be at or below 
the tachycardia detection i terval (programmable from 600 to 
250 ms). Five of six consecutive sensed cycle lengths between 
100 and 250 ms are classified as a ventricular fibrillation 
detection. Events with 7 of 10 cycle lengths -<100 ms apart are 
classified as "noise," and no antitachycardia therapy is deliv- 
ered. 
The CPI PRx utilizes automatic gain-adjusting sensing 
amplifiers with a maximal sensitivity of 0.2 inV. Tachycardia 
detection occurs when a rate-counting "bin" is filled to a 
preprogrammed value of 8 to 24 beats. Each ventricular cycle 
length equal to or below the tachycardia detection interval 
(600 to 250 ms) increments he bin counter by a value of 1. 
Each subsequent interval onger than the detection interval 
decrements the counter by a value of 1 back toward a minimal 
value of zero. The bin counts for tachycardia detection are 
separately programmable for each tachycardia therapy zone. 
Both devices provide noncommitted antitachycardia p cing 
and shock therapies by reconfirming the persistence of tachy- 
cardia immediately before delivery of therapy. The time and 
date assigned to recorded events are referenced to time 
calibrations within the respective programmers. The program- 
mers were set to correct local time at implantation and during 
follow-up. The recorded times of tachycardia detections were 
corrected for changes to and from daylight savings time during 
follow-up. The Guardian 4210 records time to the hour and 
minute. The PRx records time to the hour, minute and second. 
For both devices the internal clock accuracy is within 0.03% of 
the time elapsed since recorded events. The Guardian 4210 
stores data on up to 500 detections (depending on program- 
ming), and the PRx stores up to 128 detections before over- 
writing of the most remote pisodes occurs. 
Patients. All patients undergoing implantation of Telec- 
tronics 4210 Guardian ATP or CPI PRx defibrillators at the 
Medical College of Virginia, McGuire Veterans Administra- 
tion Hospital and Norfolk General Hospital between Septem- 
ber 25, 1990 and April 1, 1993 were eligible for inclusion in the 
study. Each patient gave informed written consent to implan- 
tation protocols approved by the hospital's Committee for the 
Conduct of Human Research. Patients were excluded from the 
study if no tachycardia detections occurred uring follow-up; if 
the time, date or defibrillator response to tachycardia detections 
was not available for any episodes from data logs; or if tachycardia 
detections occurred that were known or suspected toresult from 
supraventricular t chycardias, lead or generator malfunction or 
electromagnetic noise. Patients receiving beta-adrenergic block- 
ing agents at any time during follow-up were also excluded. 
Defibrillator implantation and follow-up. All devices were 
implanted using standard surgical techniques (16). All defibril- 
lators were activated within 48 h of implantation. Each patient 
underwent device interrogation for detected tachycardia 
events, and appropriate pacing and sensing were confirmed 
before hospital discharge and at 1, 2, 4 and 6 months after 
discharge. Each patient underwent arrhythmia induction for 
device testing before hospital discharge and at 2 to 4 months 
after discharge. Tachycardia detections resulting from device 
testing were not included in the data analysis. The data logs 
were read at each follow-up (every 2 to 6 months) and as 
clinically indicated to evaluate suspected arrhythmic events. 
The classification of detections as caused by ventricular tachy- 
arrhythmias, supraventricular tachycardias or noise in the 
absence of electrocardiographic documentation followed pre- 
viously published criteria (17-19). Detections were classified as 
ventricular tachycardia f accompanied by syncope, presyn- 
cope, typical prodromal symptoms of ventricular tachycardia 
for a given patient or by distinct changes in configuration of 
stored electrograms. Ventricular fibrillation was diagnosed if
the recorded mean RR interval was -<250 ms and accompanied 
by symptoms of hemodynamic compromise or changes in the 
configuration of stored electrograms. 
For supraventricular tachycardias, inus tachycardia was 
diagnosed if detections occurred without symptoms during 
physical exertion likely to cause sinus tachycardia. Detections 
were classified as atrial fibrillation if irregular predetection RR 
intervals (>60-ms differences) were recorded without symp- 
toms of ventricular tachyarrhythmias or without change in 
configuration of available stored electrograms. Other su- 
praventricular tachycardias were diagnosed on the basis of 
previously documented supraventricular tachycardias nd reg- 
ular RR intervals at the same rate as supraventricular tachy- 
cardia ventricular tachycardia. The difficulty of diagnosing 
supraventricular rhythmias in the absence of atrial record- 
ings even with ventricular electrograms has been recognized in 
previous studies (18). Noise detections were classified by 
irregular closely coupled RR intervals (<70 ms) that were 
reproduced by manipulation fthe device or lead or associated 
with other evidence of lead or generator malfunction. Aaltiar- 
rhythmic agents were prescribed at the discretion of the clinical 
investigators. Detections receiving multiple therapies were 
counted as a single event. 
Statistics. To minimize skewing of the sample distribution 
by those patients with the largest number of detections, a
weighted sum of hourly events was calculated for each hour for 
each patient. This weighted hourly sum was obtained by 
dividing the number of episodes recorded by a patient during 
any given hour of the day by the total number of episodes 
recorded for that same patient during follow-up. For example, 
if a patient recorded a total of 20 episodes during 1 year of 
follow-up, and 5 episodes occurred between 3 and 4 P.M. (on 
the same or separate days), the weighted frequency of episodes 
for this patient for the hour 3 to 4 P.M. would be 5/20, or 0.25. 
This weighting process gives each patient equal representation 
in the temporal distribution of events. 
To investigate the pattern of circadian distributions, the 
data were fitted to a Loess curve. This iterative weighted 
least-squares method of fitting a smooth curve requires no 
preanalysis assumptions about he distributional pattern. For 
all cases in which there was a pattern, the Loess fit was 
consistent with a single peak and trough corresponding to a 
sine curve or cubic fit. In all cases but one (shock only), the sine 
function provided a closer fit to sample distributions than cubic 
fits. The fitted sine curve function is given by 
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Figure 1. Unweighted circadian distribution over the 24-h day of all 
830 ventricular tachycardia detections from the 43 study patients. 
y = a + a 0 sin[2n/24(x - 6) - al], 
where y = relative episode frequency; a = y intercept; a 0 = 
amplitude; x = hour of frequency sample; and a~ = time of 
peak frequency. In the sine model, peak and trough frequen- 
cies are separated by 12 h. Asymptotic 95% confidence inter- 
vals were calculated for times of peak frequencies. The level of 
significance was set at p = 0.05. Results are expressed as mean 
value _+ SD. Correlation coetficients between observed and 
fitted temporal distributions were calculated as (1 - Residual 
SS/corrected SS) t/2, where residual SS = sum of squared 
differences between the observed and fitted data; and cor- 
rected SS = sum of squared deviations around the mean value. 
A curve was described as statistically fitting a group of data if 
the calculated 95% confidence intervals for the variable esti- 
mates of curvature did not include zero. All analysis was 
performed with commercially available computer software 
(SAS version 6.06 and SPSS version 6.0). 
Resu l ts  
Study patients. Forty-three of 114 patients receiving defi- 
brillators were included in the study. A total of 71 patients 
were excluded for absence of tachycardia detections during 
follow-up (n = 35), incomplete data logs (n = 13), detections 
caused by supraventricular tachycardia or noise (n = 21) or 
beta-blocker use (n = 3). Only one patient was excluded for 
complete filling over the defibrillator data storage capacity 
(Guardian 4210). Other incomplete data log exclusions re- 
sulted from clearing data logs before downloading of data or 
loss of previously downloaded information. 
The mean (_+SD) age of the study group was 62.9 _+ 12.8 
years (37 men [86%], 6 women [14%]). Coronary artery 
disease was present in 35 patients (81%), idiopathic cardio- 
myopathy in 6 (15%) and hypertrophic and vasculitic cardio- 
myopathies in 1 each (2%). The average left ventricular 
ejection fraction was 33 _+ 10%. The indications for defibril- 
lator implantation were ventricular tachycardia in 33 (76.7%), 
ventricular fibrillation in 8 (18.6%) and sudden cardiac death 
in 2 (4.6%). Twenty-one patients received antiarrhythmic drug 
therapy at some time during follow-up (see later). Seventeen 
patients received the Telectronics 4210, and 26 patients re- 
ceived the CPI PRx. Mean follow-up duration was 226 _+ 179 
days (range 5 to 782). 
Circadian distribution of tachycardia detections. A total 
of 830 tachycardia detections were recorded by the 43 study 
patients (mean number of detections/patient 16 _+ 25, median 
7, range 1 to 114). The unweighted frequency of all 830 tachycar- 
dia detections by the hour of the day is shown in Figure 1. The 
interval with the most tachycardia episodes was 2 to 5 e.M., and 
the fewest detections occurred from 2 to 3 A.M. 
Results of curve fitting for the weighted frequency distribu- 
tions for different detection types is shown in Table 1. Signif- 
icant circadian variability was demonstrated for analysis of all 
Table I. Results of Fitting Sine Curve Model to Data Defined by Different Detection Criteria 
No. of No. of p Corr 
Detection Type Pts Detections Value* Coeff Peak 95% CI 
All pts 43 830 < 0.05 0.75 2:43 p.~,l. 1:13-4:13 P.M. 
Pts with CAD 35 701 < {).05 0.73 2:55 P.M. 1:25-4:25 P.M. 
Spontaneous terminations 21 319 < 0.05 0.53 2:20 P.M. 11:38-5:07 P.M. 
Shock or ATP 40 511 < 0.05 0.67 2:08 P.M. 12:15-4:02 P.M. 
Shock 37 3112 <0.05 0.56 3:09 P.M. 12:34-5:44 e.M. 
Off medications 22 250 < 0.05 0.71 2:11 PAI. 12:29-3:54 P.M. 
On medications 15 430 NS - -  - -  -- 
All compressed 43 524 < 0.05 0.73 2:29 P.M. 1:00-3:59 P.M. 
Compressed off medications 22 147 < 0.05 0.73 2:15 P.M. 12:39-3:52 P.M. 
Compressed onmedications 15 261 NS --  -- - -  
*Significance offit between sample and fitted sine curve distributions. All = all 830 detections from 43 study patients 
(Pts); All compressed = detections from all patients after counting all episodes occurring within 1 min as a single pisode; 
CAD - corona~, artev disease; Corr Coeff - correlation coefficient (R value) between sample and fitted sine curve 
distributions; On (Off) medications detections recorded from patients with (without) antiarrhythmic drugs during 
follow-up; Peak - time of maximal event frequency; Shock = detections terminating after eceiving shock therapy; Shock 
or ATP = taehycardia detections terminating after any implantable cardioverter-defibrillator therapy; Spontaneous 
terminations - tachycardia detections terminating without any implantable cardioverter-defibrillator therapy; 95% CI - 
95% confidence interval. 
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Figure 2. Circadian distribution for the weighted frequency of all 830 
tachycardia episodes from 43 patients. The fitted sine curve model is 
shown (R = 0.75). 
detections, detections only from patients with coronary artery 
disease, detections that resolved spontaneously without deliv- 
ered therapy, detections receiving any form of device therapy, 
shock therapy alone and those episodes occurring in the 
absence of any antiarrhythmic drug therapy during follow-up, 
all with peak frequencies between 2:08 and 3:09 P.M. (all 95% 
confidence intervals between 11:38 A.~. and 5:44 P.M.) (Table 
1, Fig. 2 and 3). Detections recorded from the 15 patients 
taking antiarrhythmic drug therapy continuously throughout 
follow-up failed to demonstrate significant circadian variability 
(p > 0.05) (Fig. 4). Four of these patients took procainamide or 
disopyramide, 2took mexiletine, 3 took propafenone, and 11 took 
amiodarone. Four patients changed drug therapy during follow- 
up, and two were taking combination therapy. The six patients 
beginning antiarrhythmic therapy after an initial follow-up with 
no drugs were excluded from this analysis. 
To control for the possibility that closely coupled runs of 
essentially continuous arrhythmias could skew the distribution 
by multiple counting of a single episode, all 830 episodes were 
subjected to a compressed analysis in which episodes occurring 
in the same minute for any patient were counted as a single 
episode. After data compression, 524 episodes were analyzed 
for the 43 patients (Table 1). All compressed episodes taken 
together and compressed episodes in the absence of antiar- 
rhythmic drug therapy demonstrated circadian variability (Ta- 
ble 1, Fig. 4). Compressed episodes recorded during continu- 
ous antiarrhythmic drug therapy failed to demonstrate 
circadian variability (Table 1, Fig. 4). 
Discuss ion  
The present study demonstrates a significant circadian 
pattern for the occurrence of ventricular tachyarrhythmias in a 
group of patients as detected by late-generation implantable 
cardioverter-defibrillators. These devices keep an accurate 
record of the time and date of all tachycardia detections by 
long-term and continuous monitoring of heart rate. In this 
study the weighted distribution of 830 episodes of ventricular 
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Figure 3. Circadian distri- 
butions for (A) weighted 
frequencies of spontane- 
ously resolving tachycar- 
dia episodes (R = 0.53); 
(B) episodes receiving 
shock or antitachycardia 
pacing therapy (R = 
0.67); (C) episodes receiv- 
ing shock therapy (R = 
0.56); and (D) episodes in 
the absence of antiar- 
rhythmic drug therapy 
(R = 0.71). The fitted sine 
curve models are shown. 
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Figure 4. Circadian distribu- 
tions for (A) uncompressed 
weighted frequency of epi- 
sodes occurring in the pres- 
ence of continuous antiar- 
rhythmic drug therapy; (B) 
weighted frequences of all 
compressed pisodes from 43 
patients (R = 0.73); (C) com- 
pressed episodes in the ab- 
sence of antiarrhythmic drug 
therapy (R = 0.73); and (D) 
compressed episodes in the 
presence ofcontinuous antiar- 
rhythmic drug therapy. Fitted 
sine curve models are shown 
when significant. 
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tachyarrhythmias recorded from 43 patients fit a sine curve 
model with the peak between 1:13 and 4:43 P.M. (95% CI) and 
the nadir 12 h earlier. A sine curve also described the 
distribution of spontaneously resolving episodes, episodes re- 
ceiving device therapy and episodes occurring in the absence of 
drug therapy. Episodes recorded uring continuous antiar- 
rhythmic drug therapy failed to fit this model. 
Comparison with previous tudies. Previous tudies of the 
circadian patterns of arrhythmic events (1-8) have been seri- 
ously limited technologically and methodologically. Necessary 
to the accurate demonstration f circadian patterns is long- 
term monitoring of many 24-h cycles and precise documenta- 
tion of the time of arrhythmia onset. Previous studies 
(2,4,6,8,14) using single or serial ambulatory monitors, patient- 
activated recorders or patient recollection of symptom onset 
may be subject o significant sampling errors. The inaccuracies 
of short-term onitoring may be greatly compounded by the 
extreme day-to-day variability in the frequencies ofarrhythmic 
events, such as premature ventricular beats and ventricular 
tachycardia (20,21). 
Previous studies of circadian patterns of ventricular ar- 
rhythmias have described both morning and afternoon peaks 
(Table 2). Using ambulatory electrocardiography in untreated 
patients, Valkama et al. (1), Lucente t al. (2) and Twidale et 
al. (3) have reported peak frequencies for ventricular tachycardia 
at 6 A.M., 2:29 P.M. and 10 A.M. to noon, respectively. The reported 
peak frequencies for premature ventricular complexes are also 
variable but tend to occur in the afternoon (noon to 5 P.M.) 
(6,13,22,23). A nadir in ventricular ectopic activity between 
midnight and 6 A.M. is common to most reports (Table 2), 
corresponding with circadian changes in QT interval and heart 
rate variability (24,25). 
The present study shows the commonly reported early 
morning nadir in ventricular tachycardia and a midafternoon 
peak consistent with many previous reports. Disparate findings 
in this study compared with other eports may be attributed to 
different methodology and patient populations. The present 
study utilized patients with documented malignant ventricular 
arrhythmias or sudden death. Other studies (1,5,6) have se- 
lected patients with recent myocardial infarction, hypertensive 
heart disease or frequent ventricular ectopy. Also, the im- 
planted efibrillator records only arrhythmias ofsufficient rate 
and duration to fulfill detection criteria. Isolated premature 
beats and very short or slow runs of ventricular arrhythmias 
included in other reports were not detectable in this study. 
Our findings contrast with the early morning peak incidence 
of sudden death demonstrated in many reports; however, 
secondary afternoon peaks in sudden death frequency have 
been demonstrated (12,26). The lack of coincident peaks times 
for ventricular tachycardia and sudden death may have several 
explanations. Clearly, not all episodes of ventricular arrhyth- 
mias are sustained or fatal. Differential hemodynamic toler- 
ance of morning compared with afternoon arrhythmias or a 
tendency toward faster, non-self-terminating events in morn- 
ing hours is possible. Also, although ventricular arrhythmias 
are the most frequent cause of sudden cardiac death, arrhyth- 
mias in this situation may be an expression of severe underlying 
myocardial ischemia or injury (9). The factors initiating at- 
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Table 2. Studies of Circadian Patterns of Ventricular Arrhythmias 
No. of 
Study (ref. no.) Event Pts Method Peak Nadir* Model Drugs Comments 
Lucente t al. (1) VT 94 24-h Holter 2:29 P.M. 2:30 A.M. Single cosine No Post-Ml pt 
Twidale t al. (3) VT 68 History 10 A.M. to noon Midnight Sine curve Yes Single event/pt 
Raeder et al. (7) VEA 45 24-h Holter 10 A.M. to noon 5 A .M.  Autocorrelation No Pts with prior VT 
Lanza et al. (6) PVCs 38 24-h Holter 3 P.M. 1 to 3 A.M. Mean cosine No Pt with frequent PVCs 
Canada et al. (13) PVCs 164 24-h Holter Noon to 4 P.M. 2 to 4 A.M. Spectral Unknown Pt with frequent PVCs 
analysis 
Siegel et al. (5) VEA 199 24-h Holter 6 A.'~I. to midnight Midnight to 6 A.M. Generalized No VEA during ST segment 
linear depression 
Zehender et al. (4) VEA 150 24-h Holter I 1 A.M. to 7 P.M. Midnight to 3 A.M. None No VEA during ST segment 
depression 
Valkama et al. (2) VT 34 48-h Hoher 6 A.M. to 9 P.M. Single cosine No Pt with CAD 
Gillis et al. (23) PVCs 132 48-h Holter 5 P.M. 6 A.M. Two harmonic No MI, CHF, low EF, beta- 
regressions blocker blunt peak 
Cinca et al. (11) VERP/QT 12 EPS Midnight o 9 ~.M. Noon to midnight None No Longest ERP midnight 
to 9 A.M. 
Kocovic et al. (24) QT, VEA 15 QT pacemaker 10 A.M. to 3 P.M. Midnight to 4 A.M, None No Increase VEA when QT 
short 
Huikuri et al. (25) HRV 22 24-h Holter 3 A.M. to 6 A.M. 8 A.M. tO noon Single cosine No Sudden death survivors 
Willich et al. (26) Sudden death 429 Medical records 7 A.M. to 9 A.M. Midnight to6 A.~l, TWO harmonic Yes Framingham study 
regressions 
McClelland et al. VT induction 162 EPS None None Harmonic No No difference inA.M. vs. 
(27) regression P.M. VT inducibility 
*Nadir minimal event frequency may be estimated from published ata. CAD coronary artery disease; CHF congestive h art failure; Drugs use of 
antiarrhythmic drug therapy during study period; EF = ejection fraction; EPS electrophysiologic studies; ERP effective r fractory period; HRV heart rate 
variability; MI - myocardial infarction; Model - model for statistical nalysis; Peak - maximal event frequency; pt(Pts) patient(s); QT - QT interval; VEA - 
ventricular ectopic activity, including premature ventricular contractions (PVCs) and ventricular tachycardia (VT); VERP = ventricular effective refractory period. 
rhythmias and the cardiac milieu in which they occur may be 
quite different for early morning sudden death and afternoon 
ventricular arrhythmias. 
Factors influencing circadian periodicity. The factors re- 
sponsible for the circadian distribution of ventricular arrhyth- 
mias remain speculative. Many common "triggers" for ventric- 
ular arrhythmias, such as premature ventricular beats and 
myocardial ischemia, show circadian patterns (4,27-30). Circa- 
dian changes in autonomic tone are well established, and 
considerable evidence suggests a role in cardiac arrhythmogen- 
esis (3]). During the day, sympathetically mediated shortened 
refractoriness and withdrawal of protective vagal tone may 
predispose to ventricular arrhythmias (11,25,32,33). Beta- 
adrenergic blockade has been shown to blunt or abolish the 
circadian patterns of supraventricular rhythmias, ventricular 
premature beats and myocardial ischemia (23,34). Recently, 
Hohnloser et al. (22) reported that sotalol therapy blunted the 
noontime peak frequency of ventricular arrhythmias in 28 
patients. Similarly, in our study the circadian pattern was not 
evident in patients with continuous antiarrhythmic drug ther- 
apy. However, 14 of 15 patients with drug therapy received 
amiodarone or propafenone. It is unclear whether the altered 
circadian pattern resulted from the beta-blocking properties of 
these agents or from direct antiarrhythmic drug effects (35,36). 
Study limitations. The primary limitation of this study is 
the inability to confirm absolutely each tachycardia detection 
as caused by ventricular arrhythmias. However, the combined 
use of clinical history and stored data-logging information may 
discern appropriate detections from supraventricular tachy- 
arrhythmias, lead malfunction and electrical noise with a high 
degree of accuracy (37). Although analysis of detections asso- 
ciated with only syncope or presyncope may possibly improve 
the specificity of detection classification, this approach would 
wrongly exclude asymptomatic ventricular tachycardia epi- 
sodes, which can comprise up to 47% of shocks (38). In 
addition, arrhythmias treated by antitachycardia pacing are 
frequently minimally or completely asymptomatic, and events 
at night during sleep cannot be included (39). 
The present study included only patients with a history of 
sustained ventricular arrhythmias; therefore, the study results 
may not be similar to those for other patient groups. The 
variations in a patient's leep-wake cycle are undefined, and it 
is unknown whether this influenced the study results. The 
defibrillator ecords only the subset of arrhythmic events of 
suificient rate and duration to fulfill detection criteria. Shorter 
and slower episodes are undetected. Also, no attempt was 
made to identify different circadian patterns for patient sub- 
groups on the basis of etiology of heart disease, gender, 
ventricular function, severity of heart failure, presence of 
diabetes or indication for the defibrillator. These factors may 
alter the circadian patterns of cardiac events (40). 
Drug therapy was not randomized and thus represents a
potential bias. 
Clinical implications. The demonstration that morbid car- 
diac events have a circadian pattern has important implications 
for understanding the underlying pathophysiology and may 
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afford new strategies for therapy (9,41). The identification of 
high risk time periods may allow concentration fdrug therapy 
or modified defibrillator programming accordingly. In addi- 
tion, chronobiologic analyses of physiologic data may provide 
prognostic information unobtainable from conventional stud- 
ies of means and variances. Orth-Gomer et al. (42) showed 
that an amplified and phase-shifted circadian distribution of 
ventricular ectopic activity can accurately distinguish patients 
with sudden death from survivors after myocardial infarction. 
In this analysis, following the simple mean and variance of 
ectopic activity did not identify those at risk. Such detailed 
chronobiologic analyses of ventricular tachycardia distribution 
are now possible with the use of implantable cardioverter- 
defibrillators and warrant investigation. 
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